Aurobindo obtains FDA approval for generic Colcrys
Colchicine tablets have a market value of $111 million for the 12 months ending November 2021, according to IQVIA.
Aurobindo has received the Food and Drug Administration’s stamp of approval for Colchicine tablets.
The product is the generic of Takeda’s Colcrys.
[Read more: Aurobindo obtains FDA OK for generic Lioresal]
The medication is indicated in adults and children 4 years old or older for treatment of familial Mediterranean fever.
Colchicine tablets have a market value of $111 million for the 12 months ending November 2021, according to IQVIA.
[Read more: Aurobindo obtains FDA nod for generic Tricor]